ES2043270T3 - Dispositivo distribuidor. - Google Patents

Dispositivo distribuidor.

Info

Publication number
ES2043270T3
ES2043270T3 ES90301617T ES90301617T ES2043270T3 ES 2043270 T3 ES2043270 T3 ES 2043270T3 ES 90301617 T ES90301617 T ES 90301617T ES 90301617 T ES90301617 T ES 90301617T ES 2043270 T3 ES2043270 T3 ES 2043270T3
Authority
ES
Spain
Prior art keywords
distributor device
inflated
disengage
capsule
exposure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90301617T
Other languages
English (en)
Inventor
Mcneill
Abdul Rashid
Stevens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
British Technology Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898903566A external-priority patent/GB8903566D0/en
Priority claimed from GB898921155A external-priority patent/GB8921155D0/en
Application filed by British Technology Group Ltd filed Critical British Technology Group Ltd
Application granted granted Critical
Publication of ES2043270T3 publication Critical patent/ES2043270T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Encapsulation Of And Coatings For Semiconductor Or Solid State Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Molding Of Porous Articles (AREA)
  • Materials For Medical Uses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Surgical Instruments (AREA)
  • Massaging Devices (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Eye Examination Apparatus (AREA)

Abstract

Un dispositivo de liberación controlada, el cual comprende al menos un material activo, dicha cápsula está formada por al menos dos piezas interpenetradas, la pieza macho está fabricada de un material hinchable por el agua, el cual se hincha para desencajar la pieza hembra por exposición a un medio acuoso.
ES90301617T 1989-02-16 1990-02-15 Dispositivo distribuidor. Expired - Lifetime ES2043270T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898903566A GB8903566D0 (en) 1989-02-16 1989-02-16 Drug dispensing device
GB898921155A GB8921155D0 (en) 1989-09-19 1989-09-19 Drug dispensing device

Publications (1)

Publication Number Publication Date
ES2043270T3 true ES2043270T3 (es) 1993-12-16

Family

ID=26294964

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90301617T Expired - Lifetime ES2043270T3 (es) 1989-02-16 1990-02-15 Dispositivo distribuidor.

Country Status (18)

Country Link
EP (2) EP0384646B1 (es)
JP (1) JPH0818971B2 (es)
KR (1) KR0141473B1 (es)
AT (1) ATE90202T1 (es)
AU (1) AU629915B2 (es)
CA (1) CA2047738C (es)
DE (1) DE69001831T2 (es)
DK (1) DK0384646T3 (es)
ES (1) ES2043270T3 (es)
FI (1) FI913880A7 (es)
GB (1) GB2230442B (es)
HU (1) HU207940B (es)
IE (1) IE64761B1 (es)
NO (1) NO303618B1 (es)
NZ (1) NZ232561A (es)
PT (1) PT93170B (es)
RU (1) RU2104084C1 (es)
WO (1) WO1990009168A1 (es)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5938654A (en) * 1987-06-25 1999-08-17 Alza Corporation Osmotic device for delayed delivery of agent
US5110597A (en) * 1987-06-25 1992-05-05 Alza Corporation Multi-unit delivery system
GB9004702D0 (en) * 1990-03-02 1990-04-25 Polysystems Limited Dispensing device
US5474784A (en) * 1990-03-02 1995-12-12 British Technology Group Limited Dispensing device
AU651654B2 (en) * 1992-01-14 1994-07-28 Endo Pharmaceuticals Solutions Inc. Manufacture of water-swellable hydrophilic articles and drug delivery devices
US5266325A (en) * 1990-09-28 1993-11-30 Hydro Med Science Division Of National Patent Development Corp. Preparation of homogeneous hydrogel copolymers
US5443459A (en) * 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
AU652984B2 (en) * 1992-01-14 1994-09-15 Endo Pharmaceuticals Solutions Inc. Preparation of homogeneous hydrogel copolymers
GB9223144D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Controlled release device
GB9223172D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Capsule construction
GB9223146D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Vented capsule
GB9223148D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Capsule cap
CA2156726C (en) * 1993-02-26 2000-10-17 Paula Denise Davis Bisacodyl dosage form
EP0695174B1 (en) * 1993-04-20 2003-03-19 TSRL, Inc. Multi-stage drug delivery system
GB9320732D0 (en) * 1993-10-08 1993-12-01 Scherer Corp R P Controlled delivery of liquid
GB9320733D0 (en) * 1993-10-08 1993-12-01 Scherer Corp R P Controlled release device construction
WO1995011024A1 (en) * 1993-10-19 1995-04-27 The Procter & Gamble Company Picosulphate dosage form
GB9323261D0 (en) * 1993-11-11 1994-01-05 Scherer Corp R P Dispensing device
US5516524A (en) * 1993-12-20 1996-05-14 The Procter & Gamble Company Laxative compositions containing bulk fiber
EP0758244B2 (en) * 1994-05-06 2008-02-13 Pfizer Inc. Controlled-release dosage forms of azithromycin
GB9718664D0 (en) 1997-09-04 1997-11-05 Scherer Corp R P Improvements in or relating to capsules
GB9724450D0 (en) * 1997-11-20 1998-01-14 Scherer Corp R P Delayed release device
SE9704870D0 (sv) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
AU2546399A (en) 1998-02-10 1999-08-30 Yoshitomi Pharmaceutical Industries, Ltd. Preparations with controlled release
US6322819B1 (en) 1998-10-21 2001-11-27 Shire Laboratories, Inc. Oral pulsed dose drug delivery system
FR2843302B1 (fr) 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
US6913768B2 (en) 2002-09-24 2005-07-05 Shire Laboratories, Inc. Sustained release delivery of amphetamine salts
WO2006009801A2 (en) 2004-06-17 2006-01-26 Valera Pharmaceuticals, Inc. Compositions and methods for treating central precocious puberty
NZ561400A (en) 2005-03-11 2010-02-26 Endo Pharmaceuticals Solutions Controlled release formulations of octreotide
DK1916995T4 (da) 2005-07-29 2022-10-03 Stichting Groningen Centre For Drug Res Ph-styret, pulserende indgivelsessystem, fremgangsmåder til fremstilling og anvendelse deraf
ES2812250T3 (es) 2005-11-28 2021-03-16 Marinus Pharmaceuticals Inc Formulaciones de ganaxolona y procedimientos para la preparación y uso de las mismas
EP2364701A1 (en) 2005-12-20 2011-09-14 Cenestra, Llc Omega-3 fatty acid formulations
ATE536867T1 (de) 2006-03-16 2011-12-15 Tris Pharma Inc Modifizierte freisetzungsformulierungen mit arznei-ion-austausch-harzkomplexen
WO2008062320A2 (en) 2006-10-06 2008-05-29 Eisai R&D Management Co., Ltd Extended release formulations of a proton pump inhibitor
BRPI0810606B1 (pt) 2007-04-27 2018-10-16 Endo Pharmaceuticals Solutions dispositivo de implante e processo para sua preparação
UA104866C2 (uk) 2008-06-25 2014-03-25 Ендо Фармас'Ютікалз Солюшнз Інк. Імплантат октреотиду, який містить вивільняючу речовину
WO2009158412A2 (en) 2008-06-25 2009-12-30 Endo Pharmaceuticals Solutions Inc. Sustained delivery of exenatide and other polypeptides
WO2010103367A1 (en) 2009-03-09 2010-09-16 Council Of Scientific & Industrial Research Pulsatile release composition of therapeutic agent
US20170079962A1 (en) 2009-11-11 2017-03-23 Rapamycin Holdings, Llc Oral Rapamycin Preparation and Use for Stomatitus
JP5892658B2 (ja) 2010-08-20 2016-03-23 国立大学法人 東京医科歯科大学 経大腸吸収用医薬組成物
US8916588B2 (en) 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
US8927010B2 (en) 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
BR112013024401B1 (pt) 2011-03-23 2022-01-11 Ironshore Pharmaceuticals & Development, Inc Composição farmacêutica sólida oral compreendendo um ingrediente ativo estimulante do sistema nervoso central e o uso terapêutico da mesma
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10292937B2 (en) 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
DK2739270T3 (da) * 2011-08-01 2020-04-06 Hb Biotechnologies Corp Ikke-fordøjelige kapsler til administration af fluidabsorberende materialer
RU2597156C2 (ru) * 2012-01-04 2016-09-10 УЭЛЛСЛИ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Состав с отсроченным высвобождением для уменьшения частоты мочеиспускания и способ его применения
US10278925B2 (en) 2012-01-04 2019-05-07 Wellesley Pharmaceuticals, Llc Delayed-release formulations, methods of making and use thereof
EP2830602B1 (en) 2012-03-30 2020-10-21 Micelle BioPharma, Inc. Omega-3 fatty acid ester compositions
AU2013302657B2 (en) 2012-08-15 2018-08-09 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
AU2014373683B2 (en) 2013-12-31 2020-05-07 Rapamycin Holdings, Llc Oral rapamycin nanoparticle preparations and use
EP4512394A3 (en) 2015-06-03 2025-10-22 Triastek, Inc. Dosage forms and use thereof
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
CN107847398B (zh) * 2016-05-05 2019-05-07 南京三迭纪医药科技有限公司 控制释放的药物剂型
CA3051614A1 (en) 2017-01-26 2018-08-02 Triastek, Inc. Dosage forms of controlled release at specific gastrointestinal sites
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US12458592B1 (en) 2017-09-24 2025-11-04 Tris Pharma, Inc. Extended release amphetamine tablets
US11571391B2 (en) 2018-01-09 2023-02-07 Triastek, Inc. Oral drug dosage forms compromising a fixed-dose of an ADHD non-stimulant and an ADHD stimulant

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB436236A (en) * 1934-04-26 1935-10-08 Karl Wilhelm Schmidt Improvements in and relating to a therapeutic capsule
US3952741A (en) * 1975-01-09 1976-04-27 Bend Research Inc. Controlled release delivery system by an osmotic bursting mechanism
GB2112370B (en) * 1981-09-04 1984-09-26 Ciba Geigy Ag Inhibition of scale formation and corrosion in aqueous systems
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
GB8403138D0 (en) * 1984-02-07 1984-03-14 Graham N B Sustained release of active ingredient
US4801461A (en) * 1987-01-28 1989-01-31 Alza Corporation Pseudoephedrine dosage form
US4874388A (en) * 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills

Also Published As

Publication number Publication date
GB9003503D0 (en) 1990-04-11
IE64761B1 (en) 1995-09-06
JPH04505004A (ja) 1992-09-03
DK0384646T3 (da) 1993-07-12
NZ232561A (en) 1992-02-25
EP0458887A1 (en) 1991-12-04
PT93170B (pt) 1996-12-31
AU629915B2 (en) 1992-10-15
AU5163290A (en) 1990-09-05
NO303618B1 (no) 1998-08-10
NO913081D0 (no) 1991-08-08
IE900556L (en) 1990-08-16
FI913880A0 (fi) 1991-08-16
CA2047738A1 (en) 1990-08-17
EP0384646A1 (en) 1990-08-29
KR920700617A (ko) 1992-08-10
DE69001831D1 (de) 1993-07-15
CA2047738C (en) 2000-02-15
DE69001831T2 (de) 1993-09-16
EP0384646B1 (en) 1993-06-09
RU2104084C1 (ru) 1998-02-10
GB2230442A (en) 1990-10-24
HU902238D0 (en) 1991-11-28
FI913880A7 (fi) 1991-08-16
GB2230442B (en) 1992-11-25
HU207940B (en) 1993-07-28
NO913081L (no) 1991-08-08
PT93170A (pt) 1990-08-31
ATE90202T1 (de) 1993-06-15
JPH0818971B2 (ja) 1996-02-28
WO1990009168A1 (en) 1990-08-23
HUT58509A (en) 1992-03-30
KR0141473B1 (en) 1998-06-01

Similar Documents

Publication Publication Date Title
DK0427247T3 (da) Lægemiddel indeholdende R-alpha- lipoinsyre eller S-alphalipoinsyre som aktiv bestanddel
ES2159591T3 (es) Composicion de liberacion controlada.
PE62796A1 (es) Dispositivo de liberacion de droga intravaginal conteniendo un precursor de 17b-estradiol
PT93170A (pt) Processo para a preparacao de dispositivos distribuidores nomeadamente de capsulas contendo um ingrediente activo
FI954989A0 (fi) Lääkelaastari
ATE146674T1 (de) Pharmazeutische zusammensetzung zur rektalen verabreichung von wirkstoffen mit topischer medizinischer wirkung im dickdarmniveau
ES2172242T3 (es) Composiciones oftalmicas de liberacion mantenida conteniendo medicamentos solubles en agua.
AR065073A2 (es) Una formulacion medicamentosa de sistema de matriz que tiene liberacion controlada de un compuesto activo
ATE86484T1 (de) Kontrazeptives implantat.
ES2050070B1 (es) Procedimiento para la preparacion de una composicion destinada a la liberacion prolongada y controlada de una substancia peptidica.
DE69824277D1 (de) Stabile medizinische zusammenstellungen die 4,5-epoxymorphinanderivate enthalten
MX171968B (es) Sistema de liberacion de medicamento intraoral
DK1150686T3 (da) Direkte komprimerbar matrix til kontrolleret frigivelse af daglige enkeltdoser af clarithromycin
CO5670360A2 (es) Dispositivo de retencion gastrico expandible
DK0625355T3 (da) Tablet med forbedret biologisk tilgængelighed indeholdende dichlormethylenphosphonsyre som virksomt stof
BR9205344A (pt) Sapata de freio dotada de mola retentora travada contra forcao
DK0750616T3 (da) Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser
BR0015893A (pt) Montagem de laminado que retem imagem, e, métodos de formar um laminado e um meio que retenha imagem
ES510300A0 (es) Sistema de fusion para el crecimiento de una placa dendritica.
BR0203501A (pt) Formulações de multipartìculas biomoduladas
PT98416A (pt) Processo para a preparacao de um sistema matricial de silicone elastomerico autoadesivo destinado a administracao prolongada de piribedilo por via transcutanea
AR006565A1 (es) Suspensiones acuosas de beta-ciflutrina
ES2173556T3 (es) Nuevos compuestos heterociclicos, su procedimiento de preparacion y los compuestos farmaceuticos que los contienen.
ATE110261T1 (de) Feste orale applikationsformen, die als wirkstoff ifosfamid enthalten.
BR0008197A (pt) Microcápsulas para a liberação prolongada de fármacos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 384646

Country of ref document: ES